522
Participants
Start Date
July 28, 2020
Primary Completion Date
January 3, 2023
Study Completion Date
March 24, 2025
Atezolizumab
Atezolizumab 1200 mg will be administered at a fixed dose on Day 1 of each 21-day cycle by IV infusion every 3 weeks.
Cabozantinib
Cabozantinib 60 mg (three 20-mg tablets) administered orally once daily.
Herlev Hospital, Herlev
Orange Hospital, Orange
Bendigo Cancer Centre, Bendigo
Icon Cancer Foundation, South Brisbane
Hospital San Pedro De Alcantara, Cáceres
Mount Sinai Medical Center, New York
Fondazione del Piemonte per l?Oncologia (IRCCS), Candiolo (TO)
Montefiore Medical Center, The Bronx
New York Oncology Hematology,P.C.-Albany, Albany
Attikon University General Hospital, Athens
SUNY Upstate Medical University, Syracuse
CHA Bundang Medical Center, Gyeonggi-do
Seoul National University Bundang Hospital, Gyeonggi-do
Hospital Universitario Reina Sofia, Córdoba
Centre Francois Baclesse, Caen
Fox Chase Cancer Center, Philadelphia
Istituto Clinico Humanitas, Rozzano
Irccs Istituto Nazionale Dei Tumori (Int), Milan
Virginia Cancer Specialists - Gainsville, Gainesville
Uniklinik-Eppendorf, Hamburg
CHU Besançon - Hôpital Jean Minjoz, Besançon
Asst Degli Spedali Civili Di Brescia, Brescia
Hospital Lucus Augusti, Lugo
Fondazione Salvatore Maugeri, Pavia
Duke University Medical Center, Durham
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Ramon y Cajal, Madrid
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Hospital Universitario Virgen de Arrixaca, Murcia
Med. Hochschule Hannover, Hämatologie, Hämostaseologie, Onkologie u. Stammzelltransplantation, Hanover
Hospital de Navarra, Navarra
Woodlands Medical Specialists, P.A., Pensacola
Hospital Univ. Central de Asturias, Oviedo
CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre, Bordeaux
Moffitt Cancer Center, Tampa
Chungnam National University Hospital, Daejeon
Hospital Alvaro Cunqueiro, Vigo
A.O.U di Verona Policlinico G.B. Rossi, Verona
Hospital Universitario Marques de Valdecilla, Santander
Azienda Ospedaliero-Universitaria S.Orsola-Malpighi, Bologna
University Hospital of Larissa, Larissa
Cleveland Clinic, Cleveland
Hospital Universitario la Fe, Valencia
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola
Universitaetsklinikum Muenster, Münster
Pusan National University Yangsan Hospital, Gyeongsangnam-do
Minnesota Oncology Hematology, Minneapolis
Chonnam National University Hwasun Hospital, Jeollanam-do
Centre Oscar Lambret, Lille
Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt
Ospedale Di Macerata, Macerata
ICANS, Strasbourg
A.O. Universitaria Ospedale Consorziale Policlinico Di Bari, Bari
Universitätsklinikum Tübingen, Tübingen
Hopital Europeen Georges Pompidou, Paris
Texas Oncology - Central South, Austin
Universitaetsklinikum Freiburg, Freiburg im Breisgau
University of Colorado, Aurora
Rocky Mountain Cancer Center - Denver, Littleton
Istituto Tumori Napoli, Napoli
Klinikum rechts der Isar der TU München, München
University Of Utah, Salt Lake City
Universitätsklinikum Ulm, Ulm
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley, Las Vegas
UCLA, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
UC San Diego Health System, La Jolla
Institut Gustave Roussy, Villejuif
"SBIH Moscow Clinical Scientific and Practical Center named after A.S. Loginov of DHM", Moskva
"FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin", Moscow
"Branch of the company Hadassah Medical LTD", Innovatsionnogo Tsentra Skolkovo
Regional Clinical Oncology Hospital, Yaroslavl
St-Petersburg Regional Oncology Dispensary, Kuzmolovo
Private Healthcare Institution Clinical Hospital RZhD Medicine, Saint Petersburg
AV Medical Ltd., Saint Petersburg
Medical Center Avicenna, Novosibirsk
University of Arizona, Tucson
Dana-Farber Cancer Institute, Boston
Memorial Sloan Kettering - Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Fundación CENIT para la Investigación en Neurociencias, Buenos Aires
Inst. Alexander Fleming, Buenos Aires
Hospital Britanico, Ciudad Autonoma Bs As
Centro Medico Austral OMI, Ciudad Autonoma Buenos Aires
St. Joseph's Healthcare Hamilton, Hamilton
Princess Margaret Cancer Center, Toronto
Zeisigwaldkliniken Bethanien, Chemnitz
Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie, Halle
Alexandras General Hospital of Athens, Athens
Athens Medical Center, Athens
Diavalkaniko Hospital, Thessaloniki
"Policlinico Universitario Agostino Gemelli", Rome
Azienda Ospedaliera S. Maria - Terni, Terni
Hokkaido University Hospital, Hokkaido
University of Tsukuba Hospital, Ibaraki
Yokohama City University Hospital, Kanagawa
Okayama University Hospital, Okayama
Osaka Metropolitan University Hospital, Osaka
Tokushima University Hospital, Tokushima
Keio University Hospital, Tokyo
Tokyo Women's Medical University Hospital, Tokyo
Centrum Terapii Wspolczesnej J.M.Jasnorzewska Spolka Komandytowo-Akcyjna, ?ód?
Centrum Onkologii im. Prof. Franciszka ?ukaszczyka, Bydgoszcz
SP ZOZ Wojewódzki Szpital Specjalistyczny nr 4, Bytom
Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, Otwock
Szpital Kliniczny im. Heliodora ?wi?cickiego UM w Poznaniu, Późna
Szpital Grochowski im. dr med. Rafa?a Masztaka Sp. z o.o., Warsaw
Wojskowy Instytut Medyczny, Warsaw
Dolno?l?skie Centrum Onkologii, Pulmonologii i Hematologii, Wroc?aw
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Hospital Universitario Son Espases, Palma de Mallorca
Corporacio Sanitaria Parc Tauli, Sabadell
Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitario de Burgos, Burgos
Royal Blackburn Hospital, Blackburn
Barts & London School of Med, London
Royal Marsden Hospital, London
Christie Hospital Nhs Trust, Manchester
Collaborators (2)
Exelixis
INDUSTRY
Chugai Pharmaceutical
INDUSTRY
Hoffmann-La Roche
INDUSTRY